$28.07
-0.16-0.57%
At close: Aug 17, 5:00 PM EST
$28.12
0.0480.17%
After Hours: 7:31 PM EST
Collegium Pharmaceutical Inc
COLLNASDAQ
Collegium Pharmaceutical Earnings & Forecasts
Collegium Pharmaceutical (COLL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Collegium Pharmaceutical Guidance
Collegium Pharmaceutical (COLL) last issued guidance on August 6, 2026 for fiscal year 2026. The company guided revenue in the range of $825M - $855M for the period.
Compared to prior guidance, Collegium Pharmaceutical lowered its revenue forecast from a prior range of $865M - $895M.
Collegium Pharmaceutical has issued 23 guidance updates between November 3, 2022 and August 6, 2026. During this period, the company raised its outlook 8 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.70 | $1.46 | $2.09 | $1.79 |
| Actual | $1.92 | $1.76 | $2.04 | $2.25 |
| Surprise | +12.9% | +20.5% | -2.39% | +25.7% |
| Revenue | ||||
| Estimate | $202.3M | $183.7M | $207.3M | $189.4M |
| Actual | $199.9M | $193.5M | $205.4M | $209.4M |
| Surprise | -1.19% | +5.32% | -0.88% | +10.6% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.86 | $2.00 | $1.04 | $1.20 |
| Revenue | ||||
| Consensus | $217.8M | $224.6M | — | — |
